The long-term survival of a patient with pancreatic cancer with metastases to the liver after results with the intravenous alpha-lipoic acid/low-dose naltrexone protocol
Cytoprotection against Cr6+-induced DNA damage by alpha-lipoic acid: implications in reducing occupational cancer risk
